Table 3 Correlation between PLOD2 expression and clinicopathological characteristics of laryngeal cancer patients
Characteristics | PLOD2 | χ2 test p | Fisher’s exact test p | |
|---|---|---|---|---|
Low, no. cases (%) | High, no. cases (%) | |||
Clinical stage | ||||
I&II | 38 (64.4) | 16 (29.1) | < 0.001 | < 0.001 |
III&IV | 21 (35.6) | 39 (70.9) | ||
T classification | ||||
T1& T2 | 42 (71.2) | 17 (30.9) | < 0.001 | < 0.001 |
T3& T4 | 17 (28.8) | 38 (69.1) | ||
N classification | ||||
N0 | 49 (83.1) | 37 (67.3) | 0.051 | 0.080 |
N1& N2& N3 | 10 (16.9) | 18 (32.7) | ||
M classification | ||||
No | 56 (94.9) | 47 (85.5) | 0.087 | 0.116 |
Yes | 3 (5.1) | 8 (14.5) | ||
Expression of CD44 | ||||
Low expression | 50 (84.7) | 7 (12.7) | < 0.001 | < 0.001 |
High expression | 9 (15.3) | 48 (87.3) | ||
Expression of CD133 | ||||
Low expression | 46 (78.0) | 16 (29.1) | < 0.001 | < 0.001 |
High expression | 13 (22.0) | 39 (70.9) | ||
Age (years) | ||||
< 62 | 30 (50.8) | 26 (47.3) | 0.703 | 0.712 |
≥ 62 | 29 (49.2) | 29 (52.7) | ||